Research Article

Efficacy of orthoMTA, retroMTA and ferric sulphate as pulpotomy agents in primary molars: A randomized clinical trial

Volume: 57 Number: 3 September 28, 2023
EN

Efficacy of orthoMTA, retroMTA and ferric sulphate as pulpotomy agents in primary molars: A randomized clinical trial

Abstract

Purpose: The purpose of this study is to evaluate the clinical and radiographic success rates of RetroMTA, OrthoMTA, and ferric sulfate as pulpotomy agents in primary molars. Patients and Methods: Ninety-six primary second molars from 32 children aged 5 to 9 years were enrolled in this study. The teeth were randomly divided into three groups based on the pulpotomy agent used: O-MTA, R-MTA, and FS. Clinical and radiographic follow-up examinations were conducted at 3, 6, 9, and 18 months postoperatively. Results: At the end of the study period, 84 teeth were evaluated. The clinical success rates were 75% for FS, 96.4% for O-MTA, and 92.8% for R-MTA groups. In the radiographic analysis, the success rates at the 18-month follow-up period were 50% for FS, 85.8% for O-MTA, and 82.2% for R-MTA groups. According to the Chi-square test and Kaplan-Meier survival analysis, there was a statistically significant difference among the success rates and survival probabilities of the groups (p<0.05). Conclusion: OrthoMTA and RetroMTA demonstrated better treatment outcomes for pulpotomy of primary second molars than ferric sulfate at the 18-month follow-up period.

Keywords

Supporting Institution

This study did not use any additional fund.

References

  1. Coll JA, Seale NS, Vargas K, Marghalani AA, Al SS, Graham L. Primary Tooth Vital Pulp Therapy: A Systematic Review and Meta-analysis. Pediatr Dent 2017;39:16-123. google scholar
  2. Asgary S, Shirvani A, Fazlyab M. MTA and Ferric Sulfate in Pulpotomy Outcomes of Primary Molars: A Systematic Review and Meta-Analysis. J Clin Pediatr Dent 2014;39: 1-8. google scholar
  3. Ranly DM. Pulpotomy therapy in primary teeth: new modalities for old rationales. Pediatr Dent 1994; 16:403-9. google scholar
  4. Agamy HA, Bakry NS, Mounir MMF, Avery DR. Comparison of mineral trioxide aggregate and formocresol as pulp-capping agents in pulpotomized primary teeth. Pediatr Dent 2004;26:302-9. google scholar
  5. Ibricevic H, al-Jame Q. Ferric sulfate as pulpotomy agent in primary teeth: twenty month clinical follow-up. J Clin Pediatr Dent 2000;24:269-72. google scholar
  6. Lemon RR, Steele PJ, Jeansonne BG. Ferric sulfate hemostasis: Effect on osseous wound healing. I. Left in situ for maximum exposure. J Endod 1993;19:170-3. google scholar
  7. Sonmez D, Sari S, Çetinbaş T. A Comparison of Four Pulpotomy Techniques in Primary google scholar
  8. Silva LLCE, Cosme-Silva L, Sakai VT, Lopes CS, Silveira APPD, Moretti RN, Moretti ABD S. Comparison between calcium hydroxide mixtures and mineral trioxide aggregate in primary teeth pulpotomy: a randomized controlled trial. J Appl Oral Sci 2019;27:1-8. google scholar

Details

Primary Language

English

Subjects

Dentistry (Other)

Journal Section

Research Article

Publication Date

September 28, 2023

Submission Date

June 9, 2021

Acceptance Date

May 5, 2023

Published in Issue

Year 2023 Volume: 57 Number: 3

APA
Yılmaz, S., & Keleş, S. (2023). Efficacy of orthoMTA, retroMTA and ferric sulphate as pulpotomy agents in primary molars: A randomized clinical trial. European Oral Research, 57(3), 144-150. https://doi.org/10.26650/eor.2023950004
AMA
1.Yılmaz S, Keleş S. Efficacy of orthoMTA, retroMTA and ferric sulphate as pulpotomy agents in primary molars: A randomized clinical trial. EOR. 2023;57(3):144-150. doi:10.26650/eor.2023950004
Chicago
Yılmaz, Sıla, and Sultan Keleş. 2023. “Efficacy of OrthoMTA, RetroMTA and Ferric Sulphate As Pulpotomy Agents in Primary Molars: A Randomized Clinical Trial”. European Oral Research 57 (3): 144-50. https://doi.org/10.26650/eor.2023950004.
EndNote
Yılmaz S, Keleş S (September 1, 2023) Efficacy of orthoMTA, retroMTA and ferric sulphate as pulpotomy agents in primary molars: A randomized clinical trial. European Oral Research 57 3 144–150.
IEEE
[1]S. Yılmaz and S. Keleş, “Efficacy of orthoMTA, retroMTA and ferric sulphate as pulpotomy agents in primary molars: A randomized clinical trial”, EOR, vol. 57, no. 3, pp. 144–150, Sept. 2023, doi: 10.26650/eor.2023950004.
ISNAD
Yılmaz, Sıla - Keleş, Sultan. “Efficacy of OrthoMTA, RetroMTA and Ferric Sulphate As Pulpotomy Agents in Primary Molars: A Randomized Clinical Trial”. European Oral Research 57/3 (September 1, 2023): 144-150. https://doi.org/10.26650/eor.2023950004.
JAMA
1.Yılmaz S, Keleş S. Efficacy of orthoMTA, retroMTA and ferric sulphate as pulpotomy agents in primary molars: A randomized clinical trial. EOR. 2023;57:144–150.
MLA
Yılmaz, Sıla, and Sultan Keleş. “Efficacy of OrthoMTA, RetroMTA and Ferric Sulphate As Pulpotomy Agents in Primary Molars: A Randomized Clinical Trial”. European Oral Research, vol. 57, no. 3, Sept. 2023, pp. 144-50, doi:10.26650/eor.2023950004.
Vancouver
1.Sıla Yılmaz, Sultan Keleş. Efficacy of orthoMTA, retroMTA and ferric sulphate as pulpotomy agents in primary molars: A randomized clinical trial. EOR. 2023 Sep. 1;57(3):144-50. doi:10.26650/eor.2023950004